Connect Sign In
2012135
Herpes Simplex Virus Type 2 (HSV-2) IgG Inhibition, by ELISA
HSV2 INHIB
Ordering Recommendation
Not a first-line test for herpes simplex virus (HSV) 2 typing.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Plain red or serum separator tube (SST).
Specimen Preparation
Transfer 1 mL serum to an ARUP standard transport tube. (Min: 0.5 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Storage/Transport Temperature
Refrigerated. Also acceptable: Room temperature or frozen.
Unacceptable Conditions
Remarks
Stability
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: 1 month
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay (ELISA)
Performed
Varies
Reported
6-11 days
Reference Interval
By report
Interpretive Data
Compliance Category
Performed by non-ARUP Laboratory
Note
Inhibition studies are not performed on specimens with equivocal or negative results.
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
86696
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2012136 | HSV-2 IgG Screening Index | 5209-2 |
| 2012137 | HSV-2 IgG Inhibition Percent | 43180-9 |
| 2012138 | HSV-2 IgG Inhibition Interpretation |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Herpes Simplex Virus Type 2 (HSV-2) IgG Inhibition, by ELISA
Quest Diagnostics Infectious Disease Inc.
